nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP2C9—brain cancer	0.554	1	CbGaD
Aprepitant—CYP1A2—Carmustine—brain cancer	0.0608	0.308	CbGbCtD
Aprepitant—CYP3A4—Temozolomide—brain cancer	0.0459	0.233	CbGbCtD
Aprepitant—CYP3A4—Lomustine—brain cancer	0.0391	0.198	CbGbCtD
Aprepitant—CYP3A5—Etoposide—brain cancer	0.0242	0.123	CbGbCtD
Aprepitant—CYP1A2—Etoposide—brain cancer	0.018	0.0913	CbGbCtD
Aprepitant—TACR1—trigeminal nerve—brain cancer	0.012	0.19	CbGeAlD
Aprepitant—CYP3A4—Etoposide—brain cancer	0.00944	0.0478	CbGbCtD
Aprepitant—TACR1—cranial nerve—brain cancer	0.00858	0.135	CbGeAlD
Aprepitant—TACR3—hindbrain—brain cancer	0.00851	0.134	CbGeAlD
Aprepitant—TACR3—brainstem—brain cancer	0.00488	0.0768	CbGeAlD
Aprepitant—TACR1—ganglion—brain cancer	0.00434	0.0684	CbGeAlD
Aprepitant—TACR3—telencephalon—brain cancer	0.00433	0.0682	CbGeAlD
Aprepitant—TACR3—head—brain cancer	0.00269	0.0425	CbGeAlD
Aprepitant—TACR3—central nervous system—brain cancer	0.00246	0.0388	CbGeAlD
Aprepitant—TACR3—cerebellum—brain cancer	0.0024	0.0379	CbGeAlD
Aprepitant—TACR3—brain—brain cancer	0.00195	0.0308	CbGeAlD
Aprepitant—TACR1—brainstem—brain cancer	0.00189	0.0298	CbGeAlD
Aprepitant—TACR1—telencephalon—brain cancer	0.00168	0.0264	CbGeAlD
Aprepitant—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00144	0.0342	CbGpPWpGaD
Aprepitant—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00131	0.0311	CbGpPWpGaD
Aprepitant—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00123	0.0294	CbGpPWpGaD
Aprepitant—TACR1—spinal cord—brain cancer	0.00117	0.0185	CbGeAlD
Aprepitant—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00112	0.0266	CbGpPWpGaD
Aprepitant—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00111	0.0265	CbGpPWpGaD
Aprepitant—TACR1—endocrine gland—brain cancer	0.00106	0.0167	CbGeAlD
Aprepitant—TACR1—head—brain cancer	0.00104	0.0164	CbGeAlD
Aprepitant—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00102	0.0242	CbGpPWpGaD
Aprepitant—TACR1—central nervous system—brain cancer	0.000952	0.015	CbGeAlD
Aprepitant—CYP3A7—endocrine gland—brain cancer	0.000903	0.0142	CbGeAlD
Aprepitant—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000892	0.0212	CbGpPWpGaD
Aprepitant—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000858	0.0204	CbGpPWpGaD
Aprepitant—TACR1—brain—brain cancer	0.000756	0.0119	CbGeAlD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000722	0.0172	CbGpPWpGaD
Aprepitant—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000689	0.0164	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—PTCH2—brain cancer	0.000666	0.0159	CbGpPWpGaD
Aprepitant—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000663	0.0158	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—TRPC6—brain cancer	0.000656	0.0156	CbGpPWpGaD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000612	0.0146	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—GFAP—brain cancer	0.000607	0.0145	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000587	0.014	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—OR14C36—brain cancer	0.000584	0.0139	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—OR4C12—brain cancer	0.000584	0.0139	CbGpPWpGaD
Aprepitant—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000537	0.0128	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—OR14C36—brain cancer	0.00053	0.0126	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—OR4C12—brain cancer	0.00053	0.0126	CbGpPWpGaD
Aprepitant—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000517	0.0123	CbGpPWpGaD
Aprepitant—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000512	0.0122	CbGpPWpGaD
Aprepitant—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000506	0.012	CbGpPWpGaD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000473	0.0113	CbGpPWpGaD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000415	0.00989	CbGpPWpGaD
Aprepitant—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000415	0.00987	CbGpPWpGaD
Aprepitant—CYP2C19—endocrine gland—brain cancer	0.000404	0.00636	CbGeAlD
Aprepitant—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000399	0.00949	CbGpPWpGaD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00037	0.00881	CbGpPWpGaD
Aprepitant—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000365	0.0087	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000351	0.00836	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—SHH—brain cancer	0.000343	0.00817	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PTCH2—brain cancer	0.000342	0.00813	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000331	0.00788	CbGpPWpGaD
Aprepitant—CYP1A2—endocrine gland—brain cancer	0.00033	0.0052	CbGeAlD
Aprepitant—TACR3—GPCR ligand binding—SMO—brain cancer	0.000325	0.00774	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—PTCH1—brain cancer	0.000325	0.00774	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—PTCH2—brain cancer	0.000325	0.00774	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—TRPC6—brain cancer	0.00032	0.00762	CbGpPWpGaD
Aprepitant—CYP3A5—endocrine gland—brain cancer	0.000318	0.00501	CbGeAlD
Aprepitant—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000315	0.00749	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—OR4C12—brain cancer	0.000313	0.00746	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—OR14C36—brain cancer	0.000313	0.00746	CbGpPWpGaD
Aprepitant—CYP2C9—endocrine gland—brain cancer	0.000313	0.00493	CbGeAlD
Aprepitant—Infestation—Temozolomide—brain cancer	0.000311	0.00217	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000309	0.00215	CcSEcCtD
Aprepitant—Nausea—Lomustine—brain cancer	0.000307	0.00214	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000307	0.00731	CbGpPWpGaD
Aprepitant—Hypotension—Procarbazine—brain cancer	0.000307	0.00214	CcSEcCtD
Aprepitant—Neuropathy peripheral—Temozolomide—brain cancer	0.000305	0.00213	CcSEcCtD
Aprepitant—Stomatitis—Temozolomide—brain cancer	0.000304	0.00212	CcSEcCtD
Aprepitant—Urinary tract infection—Temozolomide—brain cancer	0.000303	0.00211	CcSEcCtD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0003	0.00715	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000299	0.00209	CcSEcCtD
Aprepitant—Insomnia—Procarbazine—brain cancer	0.000297	0.00207	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—ABR—brain cancer	0.000295	0.00703	CbGpPWpGaD
Aprepitant—Paraesthesia—Procarbazine—brain cancer	0.000295	0.00206	CcSEcCtD
Aprepitant—Somnolence—Procarbazine—brain cancer	0.000292	0.00204	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000291	0.00203	CcSEcCtD
Aprepitant—Cramp muscle—Etoposide—brain cancer	0.000291	0.00203	CcSEcCtD
Aprepitant—Ill-defined disorder—Hydroxyurea—brain cancer	0.000289	0.00202	CcSEcCtD
Aprepitant—Anaemia—Hydroxyurea—brain cancer	0.000288	0.00201	CcSEcCtD
Aprepitant—Hypoaesthesia—Carmustine—brain cancer	0.000288	0.00201	CcSEcCtD
Aprepitant—Hallucination—Carmustine—brain cancer	0.000288	0.00201	CcSEcCtD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000286	0.00682	CbGpPWpGaD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000286	0.00681	CbGpPWpGaD
Aprepitant—Decreased appetite—Procarbazine—brain cancer	0.000286	0.00199	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—OR14C36—brain cancer	0.000285	0.00679	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—OR4C12—brain cancer	0.000285	0.00679	CbGpPWpGaD
Aprepitant—Alanine aminotransferase increased—Etoposide—brain cancer	0.000285	0.00199	CcSEcCtD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000285	0.00678	CbGpPWpGaD
Aprepitant—Connective tissue disorder—Carmustine—brain cancer	0.000284	0.00198	CcSEcCtD
Aprepitant—Fatigue—Procarbazine—brain cancer	0.000283	0.00198	CcSEcCtD
Aprepitant—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000283	0.00673	CbGpPWpGaD
Aprepitant—Malaise—Hydroxyurea—brain cancer	0.000281	0.00196	CcSEcCtD
Aprepitant—Pain—Procarbazine—brain cancer	0.000281	0.00196	CcSEcCtD
Aprepitant—Constipation—Procarbazine—brain cancer	0.000281	0.00196	CcSEcCtD
Aprepitant—Dysphagia—Etoposide—brain cancer	0.000279	0.00195	CcSEcCtD
Aprepitant—Hallucination—Temozolomide—brain cancer	0.000278	0.00194	CcSEcCtD
Aprepitant—Hypoaesthesia—Temozolomide—brain cancer	0.000278	0.00194	CcSEcCtD
Aprepitant—Pharyngitis—Temozolomide—brain cancer	0.000277	0.00194	CcSEcCtD
Aprepitant—Urinary tract disorder—Temozolomide—brain cancer	0.000276	0.00193	CcSEcCtD
Aprepitant—Connective tissue disorder—Temozolomide—brain cancer	0.000275	0.00192	CcSEcCtD
Aprepitant—Urethral disorder—Temozolomide—brain cancer	0.000274	0.00191	CcSEcCtD
Aprepitant—Sweating increased—Etoposide—brain cancer	0.000272	0.0019	CcSEcCtD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000271	0.00646	CbGpPWpGaD
Aprepitant—Feeling abnormal—Procarbazine—brain cancer	0.000271	0.00189	CcSEcCtD
Aprepitant—Eye disorder—Carmustine—brain cancer	0.00027	0.00189	CcSEcCtD
Aprepitant—Convulsion—Hydroxyurea—brain cancer	0.00027	0.00188	CcSEcCtD
Aprepitant—Gastrointestinal pain—Procarbazine—brain cancer	0.000269	0.00187	CcSEcCtD
Aprepitant—Flushing—Carmustine—brain cancer	0.000268	0.00187	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—ABR—brain cancer	0.000268	0.00638	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—DTX2—brain cancer	0.000266	0.00634	CbGpPWpGaD
Aprepitant—Erythema multiforme—Temozolomide—brain cancer	0.000264	0.00184	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000263	0.00184	CcSEcCtD
Aprepitant—Discomfort—Hydroxyurea—brain cancer	0.000262	0.00183	CcSEcCtD
Aprepitant—Neutropenia—Etoposide—brain cancer	0.000261	0.00182	CcSEcCtD
Aprepitant—Eye disorder—Temozolomide—brain cancer	0.000261	0.00182	CcSEcCtD
Aprepitant—Urticaria—Procarbazine—brain cancer	0.000261	0.00182	CcSEcCtD
Aprepitant—Tinnitus—Temozolomide—brain cancer	0.000261	0.00182	CcSEcCtD
Aprepitant—Body temperature increased—Procarbazine—brain cancer	0.00026	0.00181	CcSEcCtD
Aprepitant—Abdominal pain—Procarbazine—brain cancer	0.00026	0.00181	CcSEcCtD
Aprepitant—Flushing—Temozolomide—brain cancer	0.000259	0.00181	CcSEcCtD
Aprepitant—Cardiac disorder—Temozolomide—brain cancer	0.000259	0.00181	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—OR14C36—brain cancer	0.000259	0.00616	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—OR4C12—brain cancer	0.000259	0.00616	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000258	0.00614	CbGpPWpGaD
Aprepitant—Alopecia—Carmustine—brain cancer	0.000256	0.00178	CcSEcCtD
Aprepitant—Oedema—Hydroxyurea—brain cancer	0.000254	0.00177	CcSEcCtD
Aprepitant—Angiopathy—Temozolomide—brain cancer	0.000254	0.00177	CcSEcCtD
Aprepitant—Mental disorder—Carmustine—brain cancer	0.000253	0.00177	CcSEcCtD
Aprepitant—Infection—Hydroxyurea—brain cancer	0.000253	0.00176	CcSEcCtD
Aprepitant—Immune system disorder—Temozolomide—brain cancer	0.000253	0.00176	CcSEcCtD
Aprepitant—Mediastinal disorder—Temozolomide—brain cancer	0.000252	0.00176	CcSEcCtD
Aprepitant—Malnutrition—Carmustine—brain cancer	0.000252	0.00176	CcSEcCtD
Aprepitant—Erythema—Carmustine—brain cancer	0.000252	0.00176	CcSEcCtD
Aprepitant—Chills—Temozolomide—brain cancer	0.000251	0.00175	CcSEcCtD
Aprepitant—Pneumonia—Etoposide—brain cancer	0.000251	0.00175	CcSEcCtD
Aprepitant—Nervous system disorder—Hydroxyurea—brain cancer	0.000249	0.00174	CcSEcCtD
Aprepitant—Infestation NOS—Etoposide—brain cancer	0.000249	0.00174	CcSEcCtD
Aprepitant—Infestation—Etoposide—brain cancer	0.000249	0.00174	CcSEcCtD
Aprepitant—Thrombocytopenia—Hydroxyurea—brain cancer	0.000249	0.00174	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000247	0.00172	CcSEcCtD
Aprepitant—Alopecia—Temozolomide—brain cancer	0.000247	0.00172	CcSEcCtD
Aprepitant—Skin disorder—Hydroxyurea—brain cancer	0.000247	0.00172	CcSEcCtD
Aprepitant—Acute coronary syndrome—Etoposide—brain cancer	0.000246	0.00171	CcSEcCtD
Aprepitant—Renal failure—Etoposide—brain cancer	0.000245	0.00171	CcSEcCtD
Aprepitant—Mental disorder—Temozolomide—brain cancer	0.000245	0.00171	CcSEcCtD
Aprepitant—Neuropathy peripheral—Etoposide—brain cancer	0.000244	0.0017	CcSEcCtD
Aprepitant—Myocardial infarction—Etoposide—brain cancer	0.000244	0.0017	CcSEcCtD
Aprepitant—Back pain—Carmustine—brain cancer	0.000244	0.0017	CcSEcCtD
Aprepitant—Malnutrition—Temozolomide—brain cancer	0.000243	0.0017	CcSEcCtD
Aprepitant—Erythema—Temozolomide—brain cancer	0.000243	0.0017	CcSEcCtD
Aprepitant—Stomatitis—Etoposide—brain cancer	0.000243	0.00169	CcSEcCtD
Aprepitant—Anorexia—Hydroxyurea—brain cancer	0.000242	0.00169	CcSEcCtD
Aprepitant—Hypersensitivity—Procarbazine—brain cancer	0.000242	0.00169	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000239	0.00568	CbGpPWpGaD
Aprepitant—CYP3A4—endocrine gland—brain cancer	0.000239	0.00376	CbGeAlD
Aprepitant—Dysgeusia—Temozolomide—brain cancer	0.000238	0.00166	CcSEcCtD
Aprepitant—Tremor—Carmustine—brain cancer	0.000236	0.00165	CcSEcCtD
Aprepitant—Asthenia—Procarbazine—brain cancer	0.000236	0.00164	CcSEcCtD
Aprepitant—Back pain—Temozolomide—brain cancer	0.000235	0.00164	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—CDK4—brain cancer	0.000234	0.00557	CbGpPWpGaD
Aprepitant—Anaemia—Carmustine—brain cancer	0.000233	0.00162	CcSEcCtD
Aprepitant—Pruritus—Procarbazine—brain cancer	0.000232	0.00162	CcSEcCtD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000232	0.00552	CbGpPWpGaD
Aprepitant—Tremor—Temozolomide—brain cancer	0.000228	0.00159	CcSEcCtD
Aprepitant—Dyspnoea—Hydroxyurea—brain cancer	0.000227	0.00158	CcSEcCtD
Aprepitant—Somnolence—Hydroxyurea—brain cancer	0.000226	0.00158	CcSEcCtD
Aprepitant—Ill-defined disorder—Temozolomide—brain cancer	0.000226	0.00158	CcSEcCtD
Aprepitant—Anaemia—Temozolomide—brain cancer	0.000225	0.00157	CcSEcCtD
Aprepitant—Diarrhoea—Procarbazine—brain cancer	0.000225	0.00157	CcSEcCtD
Aprepitant—Dyspepsia—Hydroxyurea—brain cancer	0.000224	0.00156	CcSEcCtD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000223	0.00531	CbGpPWpGaD
Aprepitant—Hypoaesthesia—Etoposide—brain cancer	0.000223	0.00155	CcSEcCtD
Aprepitant—Angioedema—Temozolomide—brain cancer	0.000222	0.00155	CcSEcCtD
Aprepitant—Decreased appetite—Hydroxyurea—brain cancer	0.000221	0.00154	CcSEcCtD
Aprepitant—Urinary tract disorder—Etoposide—brain cancer	0.000221	0.00154	CcSEcCtD
Aprepitant—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000221	0.00525	CbGpPWpGaD
Aprepitant—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00022	0.00524	CbGpPWpGaD
Aprepitant—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000219	0.00153	CcSEcCtD
Aprepitant—Malaise—Temozolomide—brain cancer	0.000219	0.00153	CcSEcCtD
Aprepitant—Urethral disorder—Etoposide—brain cancer	0.000219	0.00153	CcSEcCtD
Aprepitant—Fatigue—Hydroxyurea—brain cancer	0.000219	0.00153	CcSEcCtD
Aprepitant—Convulsion—Carmustine—brain cancer	0.000218	0.00152	CcSEcCtD
Aprepitant—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000218	0.00518	CbGpPWpGaD
Aprepitant—Hypertension—Carmustine—brain cancer	0.000217	0.00152	CcSEcCtD
Aprepitant—Constipation—Hydroxyurea—brain cancer	0.000217	0.00152	CcSEcCtD
Aprepitant—Pain—Hydroxyurea—brain cancer	0.000217	0.00152	CcSEcCtD
Aprepitant—Dizziness—Procarbazine—brain cancer	0.000217	0.00152	CcSEcCtD
Aprepitant—Palpitations—Temozolomide—brain cancer	0.000215	0.0015	CcSEcCtD
Aprepitant—CYP3A4—central nervous system—brain cancer	0.000215	0.00339	CbGeAlD
Aprepitant—Myalgia—Carmustine—brain cancer	0.000214	0.0015	CcSEcCtD
Aprepitant—Chest pain—Carmustine—brain cancer	0.000214	0.0015	CcSEcCtD
Aprepitant—Anxiety—Carmustine—brain cancer	0.000214	0.00149	CcSEcCtD
Aprepitant—Cough—Temozolomide—brain cancer	0.000212	0.00148	CcSEcCtD
Aprepitant—Erythema multiforme—Etoposide—brain cancer	0.000212	0.00148	CcSEcCtD
Aprepitant—Convulsion—Temozolomide—brain cancer	0.000211	0.00147	CcSEcCtD
Aprepitant—Hypertension—Temozolomide—brain cancer	0.00021	0.00147	CcSEcCtD
Aprepitant—Feeling abnormal—Hydroxyurea—brain cancer	0.000209	0.00146	CcSEcCtD
Aprepitant—Eye disorder—Etoposide—brain cancer	0.000209	0.00146	CcSEcCtD
Aprepitant—Vomiting—Procarbazine—brain cancer	0.000209	0.00146	CcSEcCtD
Aprepitant—Cardiac disorder—Etoposide—brain cancer	0.000208	0.00145	CcSEcCtD
Aprepitant—Flushing—Etoposide—brain cancer	0.000208	0.00145	CcSEcCtD
Aprepitant—Confusional state—Carmustine—brain cancer	0.000207	0.00145	CcSEcCtD
Aprepitant—Myalgia—Temozolomide—brain cancer	0.000207	0.00145	CcSEcCtD
Aprepitant—Arthralgia—Temozolomide—brain cancer	0.000207	0.00145	CcSEcCtD
Aprepitant—Rash—Procarbazine—brain cancer	0.000207	0.00145	CcSEcCtD
Aprepitant—Dermatitis—Procarbazine—brain cancer	0.000207	0.00144	CcSEcCtD
Aprepitant—Anxiety—Temozolomide—brain cancer	0.000206	0.00144	CcSEcCtD
Aprepitant—Headache—Procarbazine—brain cancer	0.000206	0.00144	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000206	0.00144	CcSEcCtD
Aprepitant—Oedema—Carmustine—brain cancer	0.000206	0.00143	CcSEcCtD
Aprepitant—Discomfort—Temozolomide—brain cancer	0.000205	0.00143	CcSEcCtD
Aprepitant—Infection—Carmustine—brain cancer	0.000204	0.00142	CcSEcCtD
Aprepitant—Angiopathy—Etoposide—brain cancer	0.000203	0.00142	CcSEcCtD
Aprepitant—Dry mouth—Temozolomide—brain cancer	0.000203	0.00141	CcSEcCtD
Aprepitant—Immune system disorder—Etoposide—brain cancer	0.000202	0.00141	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—PTCH2—brain cancer	0.000202	0.00481	CbGpPWpGaD
Aprepitant—Mediastinal disorder—Etoposide—brain cancer	0.000202	0.00141	CcSEcCtD
Aprepitant—Thrombocytopenia—Carmustine—brain cancer	0.000201	0.0014	CcSEcCtD
Aprepitant—Body temperature increased—Hydroxyurea—brain cancer	0.000201	0.0014	CcSEcCtD
Aprepitant—Chills—Etoposide—brain cancer	0.000201	0.0014	CcSEcCtD
Aprepitant—Tachycardia—Carmustine—brain cancer	0.000201	0.0014	CcSEcCtD
Aprepitant—Confusional state—Temozolomide—brain cancer	0.0002	0.0014	CcSEcCtD
Aprepitant—Oedema—Temozolomide—brain cancer	0.000199	0.00139	CcSEcCtD
Aprepitant—Anaphylactic shock—Temozolomide—brain cancer	0.000199	0.00139	CcSEcCtD
Aprepitant—Alopecia—Etoposide—brain cancer	0.000198	0.00138	CcSEcCtD
Aprepitant—Infection—Temozolomide—brain cancer	0.000197	0.00138	CcSEcCtD
Aprepitant—Anorexia—Carmustine—brain cancer	0.000196	0.00137	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HES5—brain cancer	0.000196	0.00465	CbGpPWpGaD
Aprepitant—Nausea—Procarbazine—brain cancer	0.000195	0.00136	CcSEcCtD
Aprepitant—Nervous system disorder—Temozolomide—brain cancer	0.000195	0.00136	CcSEcCtD
Aprepitant—Thrombocytopenia—Temozolomide—brain cancer	0.000194	0.00136	CcSEcCtD
Aprepitant—Skin disorder—Temozolomide—brain cancer	0.000193	0.00135	CcSEcCtD
Aprepitant—Hypotension—Carmustine—brain cancer	0.000192	0.00134	CcSEcCtD
Aprepitant—Hyperhidrosis—Temozolomide—brain cancer	0.000192	0.00134	CcSEcCtD
Aprepitant—Dysgeusia—Etoposide—brain cancer	0.000191	0.00133	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—STRADA—brain cancer	0.00019	0.00452	CbGpPWpGaD
Aprepitant—Anorexia—Temozolomide—brain cancer	0.000189	0.00132	CcSEcCtD
Aprepitant—Back pain—Etoposide—brain cancer	0.000188	0.00131	CcSEcCtD
Aprepitant—Hypersensitivity—Hydroxyurea—brain cancer	0.000187	0.00131	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Carmustine—brain cancer	0.000187	0.00131	CcSEcCtD
Aprepitant—Muscle spasms—Etoposide—brain cancer	0.000187	0.00131	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—TRPC6—brain cancer	0.000187	0.00445	CbGpPWpGaD
Aprepitant—Insomnia—Carmustine—brain cancer	0.000186	0.0013	CcSEcCtD
Aprepitant—Paraesthesia—Carmustine—brain cancer	0.000185	0.00129	CcSEcCtD
Aprepitant—Dyspnoea—Carmustine—brain cancer	0.000183	0.00128	CcSEcCtD
Aprepitant—Somnolence—Carmustine—brain cancer	0.000183	0.00127	CcSEcCtD
Aprepitant—Asthenia—Hydroxyurea—brain cancer	0.000182	0.00127	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000181	0.00126	CcSEcCtD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000181	0.0043	CbGpPWpGaD
Aprepitant—Ill-defined disorder—Etoposide—brain cancer	0.000181	0.00126	CcSEcCtD
Aprepitant—Anaemia—Etoposide—brain cancer	0.00018	0.00126	CcSEcCtD
Aprepitant—Insomnia—Temozolomide—brain cancer	0.00018	0.00125	CcSEcCtD
Aprepitant—Decreased appetite—Carmustine—brain cancer	0.000179	0.00125	CcSEcCtD
Aprepitant—Paraesthesia—Temozolomide—brain cancer	0.000178	0.00124	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Carmustine—brain cancer	0.000177	0.00124	CcSEcCtD
Aprepitant—Dyspnoea—Temozolomide—brain cancer	0.000177	0.00124	CcSEcCtD
Aprepitant—Somnolence—Temozolomide—brain cancer	0.000177	0.00123	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—SHH—brain cancer	0.000176	0.00419	CbGpPWpGaD
Aprepitant—Pain—Carmustine—brain cancer	0.000176	0.00123	CcSEcCtD
Aprepitant—Constipation—Carmustine—brain cancer	0.000176	0.00123	CcSEcCtD
Aprepitant—Malaise—Etoposide—brain cancer	0.000176	0.00123	CcSEcCtD
Aprepitant—Dyspepsia—Temozolomide—brain cancer	0.000175	0.00122	CcSEcCtD
Aprepitant—Diarrhoea—Hydroxyurea—brain cancer	0.000174	0.00121	CcSEcCtD
Aprepitant—Decreased appetite—Temozolomide—brain cancer	0.000173	0.0012	CcSEcCtD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000172	0.0041	CbGpPWpGaD
Aprepitant—Gastrointestinal disorder—Temozolomide—brain cancer	0.000171	0.0012	CcSEcCtD
Aprepitant—Fatigue—Temozolomide—brain cancer	0.000171	0.00119	CcSEcCtD
Aprepitant—Loss of consciousness—Etoposide—brain cancer	0.000171	0.00119	CcSEcCtD
Aprepitant—Cough—Etoposide—brain cancer	0.00017	0.00119	CcSEcCtD
Aprepitant—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00017	0.00404	CbGpPWpGaD
Aprepitant—Constipation—Temozolomide—brain cancer	0.00017	0.00119	CcSEcCtD
Aprepitant—Pain—Temozolomide—brain cancer	0.00017	0.00119	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—TRPC6—brain cancer	0.00017	0.00404	CbGpPWpGaD
Aprepitant—Feeling abnormal—Carmustine—brain cancer	0.000169	0.00118	CcSEcCtD
Aprepitant—Convulsion—Etoposide—brain cancer	0.000169	0.00118	CcSEcCtD
Aprepitant—Hypertension—Etoposide—brain cancer	0.000168	0.00117	CcSEcCtD
Aprepitant—Dizziness—Hydroxyurea—brain cancer	0.000168	0.00117	CcSEcCtD
Aprepitant—Gastrointestinal pain—Carmustine—brain cancer	0.000168	0.00117	CcSEcCtD
Aprepitant—TACR1—GPCR ligand binding—SHH—brain cancer	0.000168	0.00399	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PTCH2—brain cancer	0.000167	0.00397	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—SMO—brain cancer	0.000167	0.00397	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PTCH1—brain cancer	0.000167	0.00397	CbGpPWpGaD
Aprepitant—Chest pain—Etoposide—brain cancer	0.000166	0.00116	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000165	0.00115	CcSEcCtD
Aprepitant—Discomfort—Etoposide—brain cancer	0.000164	0.00114	CcSEcCtD
Aprepitant—Feeling abnormal—Temozolomide—brain cancer	0.000164	0.00114	CcSEcCtD
Aprepitant—Abdominal pain—Carmustine—brain cancer	0.000162	0.00113	CcSEcCtD
Aprepitant—Body temperature increased—Carmustine—brain cancer	0.000162	0.00113	CcSEcCtD
Aprepitant—Gastrointestinal pain—Temozolomide—brain cancer	0.000162	0.00113	CcSEcCtD
Aprepitant—Vomiting—Hydroxyurea—brain cancer	0.000162	0.00113	CcSEcCtD
Aprepitant—Rash—Hydroxyurea—brain cancer	0.00016	0.00112	CcSEcCtD
Aprepitant—Confusional state—Etoposide—brain cancer	0.00016	0.00112	CcSEcCtD
Aprepitant—Dermatitis—Hydroxyurea—brain cancer	0.00016	0.00112	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000159	0.0038	CbGpPWpGaD
Aprepitant—Headache—Hydroxyurea—brain cancer	0.000159	0.00111	CcSEcCtD
Aprepitant—Anaphylactic shock—Etoposide—brain cancer	0.000159	0.00111	CcSEcCtD
Aprepitant—TACR1—GPCR ligand binding—PTCH1—brain cancer	0.000159	0.00378	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—SMO—brain cancer	0.000159	0.00378	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ABR—brain cancer	0.000158	0.00377	CbGpPWpGaD
Aprepitant—Infection—Etoposide—brain cancer	0.000158	0.0011	CcSEcCtD
Aprepitant—Urticaria—Temozolomide—brain cancer	0.000158	0.0011	CcSEcCtD
Aprepitant—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000157	0.00374	CbGpPWpGaD
Aprepitant—Abdominal pain—Temozolomide—brain cancer	0.000157	0.0011	CcSEcCtD
Aprepitant—Body temperature increased—Temozolomide—brain cancer	0.000157	0.0011	CcSEcCtD
Aprepitant—Thrombocytopenia—Etoposide—brain cancer	0.000156	0.00109	CcSEcCtD
Aprepitant—Tachycardia—Etoposide—brain cancer	0.000155	0.00108	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—IL2—brain cancer	0.000155	0.00369	CbGpPWpGaD
Aprepitant—Skin disorder—Etoposide—brain cancer	0.000154	0.00108	CcSEcCtD
Aprepitant—Hyperhidrosis—Etoposide—brain cancer	0.000154	0.00107	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—GLI2—brain cancer	0.000153	0.00364	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—OR14C36—brain cancer	0.000153	0.00364	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—OR4C12—brain cancer	0.000153	0.00364	CbGpPWpGaD
Aprepitant—Anorexia—Etoposide—brain cancer	0.000151	0.00106	CcSEcCtD
Aprepitant—Hypersensitivity—Carmustine—brain cancer	0.000151	0.00106	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—CCND1—brain cancer	0.000151	0.0036	CbGpPWpGaD
Aprepitant—Nausea—Hydroxyurea—brain cancer	0.000151	0.00105	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.00015	0.00358	CbGpPWpGaD
Aprepitant—Hypotension—Etoposide—brain cancer	0.000149	0.00104	CcSEcCtD
Aprepitant—Asthenia—Carmustine—brain cancer	0.000147	0.00103	CcSEcCtD
Aprepitant—Hypersensitivity—Temozolomide—brain cancer	0.000146	0.00102	CcSEcCtD
Aprepitant—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000146	0.00348	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—ABR—brain cancer	0.000144	0.00343	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GLI1—brain cancer	0.000144	0.00342	CbGpPWpGaD
Aprepitant—Paraesthesia—Etoposide—brain cancer	0.000143	0.000996	CcSEcCtD
Aprepitant—Asthenia—Temozolomide—brain cancer	0.000142	0.000994	CcSEcCtD
Aprepitant—Dyspnoea—Etoposide—brain cancer	0.000142	0.000989	CcSEcCtD
Aprepitant—Somnolence—Etoposide—brain cancer	0.000141	0.000986	CcSEcCtD
Aprepitant—Diarrhoea—Carmustine—brain cancer	0.000141	0.000981	CcSEcCtD
Aprepitant—Pruritus—Temozolomide—brain cancer	0.000141	0.000981	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—VAV1—brain cancer	0.00014	0.00333	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00014	0.00332	CbGpPWpGaD
Aprepitant—Decreased appetite—Etoposide—brain cancer	0.000138	0.000964	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Etoposide—brain cancer	0.000137	0.000957	CcSEcCtD
Aprepitant—Fatigue—Etoposide—brain cancer	0.000137	0.000956	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—SUFU—brain cancer	0.000136	0.00325	CbGpPWpGaD
Aprepitant—Dizziness—Carmustine—brain cancer	0.000136	0.000948	CcSEcCtD
Aprepitant—Pain—Etoposide—brain cancer	0.000136	0.000948	CcSEcCtD
Aprepitant—Constipation—Etoposide—brain cancer	0.000136	0.000948	CcSEcCtD
Aprepitant—Diarrhoea—Temozolomide—brain cancer	0.000136	0.000948	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—GFAP—brain cancer	0.000132	0.00313	CbGpPWpGaD
Aprepitant—Dizziness—Temozolomide—brain cancer	0.000131	0.000916	CcSEcCtD
Aprepitant—Feeling abnormal—Etoposide—brain cancer	0.000131	0.000914	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—ABR—brain cancer	0.000131	0.00312	CbGpPWpGaD
Aprepitant—Vomiting—Carmustine—brain cancer	0.000131	0.000912	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—DTX2—brain cancer	0.00013	0.0031	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Etoposide—brain cancer	0.00013	0.000907	CcSEcCtD
Aprepitant—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00013	0.00309	CbGpPWpGaD
Aprepitant—Rash—Carmustine—brain cancer	0.00013	0.000904	CcSEcCtD
Aprepitant—Dermatitis—Carmustine—brain cancer	0.000129	0.000903	CcSEcCtD
Aprepitant—Headache—Carmustine—brain cancer	0.000129	0.000898	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—VAV1—brain cancer	0.000127	0.00303	CbGpPWpGaD
Aprepitant—Vomiting—Temozolomide—brain cancer	0.000126	0.000881	CcSEcCtD
Aprepitant—Urticaria—Etoposide—brain cancer	0.000126	0.000881	CcSEcCtD
Aprepitant—Body temperature increased—Etoposide—brain cancer	0.000126	0.000877	CcSEcCtD
Aprepitant—Abdominal pain—Etoposide—brain cancer	0.000126	0.000877	CcSEcCtD
Aprepitant—Rash—Temozolomide—brain cancer	0.000125	0.000874	CcSEcCtD
Aprepitant—Dermatitis—Temozolomide—brain cancer	0.000125	0.000873	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HEY1—brain cancer	0.000125	0.00297	CbGpPWpGaD
Aprepitant—Headache—Temozolomide—brain cancer	0.000124	0.000868	CcSEcCtD
Aprepitant—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000123	0.00293	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—DLL1—brain cancer	0.000122	0.00291	CbGpPWpGaD
Aprepitant—Nausea—Carmustine—brain cancer	0.000122	0.000852	CcSEcCtD
Aprepitant—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000122	0.00289	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MYC—brain cancer	0.000121	0.00288	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.00012	0.00285	CbGpPWpGaD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000119	0.00283	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—EGFR—brain cancer	0.000119	0.00282	CbGpPWpGaD
Aprepitant—Nausea—Temozolomide—brain cancer	0.000118	0.000823	CcSEcCtD
Aprepitant—Hypersensitivity—Etoposide—brain cancer	0.000117	0.000817	CcSEcCtD
Aprepitant—Asthenia—Etoposide—brain cancer	0.000114	0.000796	CcSEcCtD
Aprepitant—Pruritus—Etoposide—brain cancer	0.000112	0.000785	CcSEcCtD
Aprepitant—Diarrhoea—Etoposide—brain cancer	0.000109	0.000759	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000105	0.00251	CbGpPWpGaD
Aprepitant—Dizziness—Etoposide—brain cancer	0.000105	0.000733	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—SHH—brain cancer	0.000104	0.00248	CbGpPWpGaD
Aprepitant—Vomiting—Etoposide—brain cancer	0.000101	0.000705	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—TRPC6—brain cancer	0.0001	0.00239	CbGpPWpGaD
Aprepitant—Rash—Etoposide—brain cancer	0.0001	0.000699	CcSEcCtD
Aprepitant—Dermatitis—Etoposide—brain cancer	0.0001	0.000699	CcSEcCtD
Aprepitant—Headache—Etoposide—brain cancer	9.96e-05	0.000695	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—TP53—brain cancer	9.95e-05	0.00237	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.91e-05	0.00236	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PTCH1—brain cancer	9.86e-05	0.00235	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SMO—brain cancer	9.86e-05	0.00235	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTCH2—brain cancer	9.86e-05	0.00235	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.61e-05	0.00229	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HES5—brain cancer	9.55e-05	0.00227	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	9.47e-05	0.00226	CbGpPWpGaD
Aprepitant—Nausea—Etoposide—brain cancer	9.44e-05	0.000659	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—STRADA—brain cancer	9.27e-05	0.00221	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TRPC6—brain cancer	9.13e-05	0.00217	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—PIK3CG—brain cancer	8.89e-05	0.00212	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—SHH—brain cancer	8.6e-05	0.00205	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TRPC6—brain cancer	8.29e-05	0.00197	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PTCH1—brain cancer	8.15e-05	0.00194	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—SMO—brain cancer	8.15e-05	0.00194	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PIK3CG—brain cancer	8.08e-05	0.00192	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NOTCH2—brain cancer	7.88e-05	0.00188	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ABR—brain cancer	7.74e-05	0.00184	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VAV1—brain cancer	7.51e-05	0.00179	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GLI2—brain cancer	7.47e-05	0.00178	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.41e-05	0.00176	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.34e-05	0.00175	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.31e-05	0.00174	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GLI1—brain cancer	7.02e-05	0.00167	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—VAV1—brain cancer	6.84e-05	0.00163	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SUFU—brain cancer	6.66e-05	0.00159	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HES1—brain cancer	6.46e-05	0.00154	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GFAP—brain cancer	6.43e-05	0.00153	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—IL2—brain cancer	6.26e-05	0.00149	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—VAV1—brain cancer	6.21e-05	0.00148	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PDGFRA—brain cancer	6.15e-05	0.00146	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HEY1—brain cancer	6.09e-05	0.00145	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—DLL1—brain cancer	5.97e-05	0.00142	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SPP1—brain cancer	5.97e-05	0.00142	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.72e-05	0.00136	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL2—brain cancer	5.68e-05	0.00135	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IRS2—brain cancer	5.4e-05	0.00129	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.15e-05	0.00123	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SHH—brain cancer	5.08e-05	0.00121	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TRPC6—brain cancer	4.9e-05	0.00117	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTCH1—brain cancer	4.81e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SMO—brain cancer	4.81e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—APC—brain cancer	4.77e-05	0.00114	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CG—brain cancer	4.77e-05	0.00114	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.73e-05	0.00113	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.38e-05	0.00104	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—EGFR—brain cancer	4.35e-05	0.00103	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CG—brain cancer	4.34e-05	0.00103	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.03e-05	0.000958	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CG—brain cancer	3.94e-05	0.000939	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.94e-05	0.000937	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.94e-05	0.000937	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH2—brain cancer	3.85e-05	0.000916	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2C9—brain cancer	3.77e-05	0.000898	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RELA—brain cancer	3.73e-05	0.000887	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ERBB2—brain cancer	3.7e-05	0.000882	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.69e-05	0.000878	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VAV1—brain cancer	3.67e-05	0.000873	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.46e-05	0.000824	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—brain cancer	3.36e-05	0.000799	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCND1—brain cancer	3.27e-05	0.000779	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CTNNB1—brain cancer	3.24e-05	0.000771	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BSG—brain cancer	3.21e-05	0.000764	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.16e-05	0.000751	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HES1—brain cancer	3.16e-05	0.000751	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—brain cancer	3.06e-05	0.000727	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PDGFRA—brain cancer	3e-05	0.000715	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPP1—brain cancer	2.92e-05	0.000694	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—brain cancer	2.85e-05	0.000679	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—STAT3—brain cancer	2.83e-05	0.000672	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—brain cancer	2.78e-05	0.000661	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—IDH1—brain cancer	2.76e-05	0.000657	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2C9—brain cancer	2.73e-05	0.000649	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.7e-05	0.000642	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IRS2—brain cancer	2.64e-05	0.000628	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MYC—brain cancer	2.63e-05	0.000625	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EGFR—brain cancer	2.57e-05	0.000611	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CG—brain cancer	2.33e-05	0.000555	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APC—brain cancer	2.33e-05	0.000555	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BSG—brain cancer	2.32e-05	0.000552	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ENO2—brain cancer	2.18e-05	0.000519	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—brain cancer	2.16e-05	0.000513	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—brain cancer	2.12e-05	0.000505	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2C9—brain cancer	2.11e-05	0.000502	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—IDH1—brain cancer	1.99e-05	0.000475	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RELA—brain cancer	1.82e-05	0.000433	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB2—brain cancer	1.81e-05	0.000431	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BSG—brain cancer	1.79e-05	0.000427	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000391	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—brain cancer	1.64e-05	0.00039	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BSG—brain cancer	1.63e-05	0.000389	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—brain cancer	1.6e-05	0.00038	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—brain cancer	1.58e-05	0.000377	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ENO2—brain cancer	1.58e-05	0.000375	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—IDH1—brain cancer	1.54e-05	0.000367	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—IDH1—brain cancer	1.41e-05	0.000335	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BSG—brain cancer	1.4e-05	0.000332	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—brain cancer	1.39e-05	0.000332	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—brain cancer	1.38e-05	0.000328	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—brain cancer	1.28e-05	0.000305	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2C9—brain cancer	1.27e-05	0.000302	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.000299	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—brain cancer	1.25e-05	0.000298	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ENO2—brain cancer	1.22e-05	0.00029	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—IDH1—brain cancer	1.2e-05	0.000286	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.14e-05	0.000272	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO2—brain cancer	1.11e-05	0.000264	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BSG—brain cancer	1.08e-05	0.000257	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—brain cancer	1.05e-05	0.000251	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—brain cancer	1e-05	0.000238	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.78e-06	0.000233	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO2—brain cancer	9.49e-06	0.000226	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH1—brain cancer	9.27e-06	0.000221	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO2—brain cancer	7.33e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—brain cancer	7.23e-06	0.000172	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—brain cancer	5.59e-06	0.000133	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—brain cancer	5.1e-06	0.000121	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—brain cancer	4.36e-06	0.000104	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—brain cancer	3.36e-06	8e-05	CbGpPWpGaD
